Xiang Wang

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 2

Top Topics

Clinical Evaluation

Tyrosine Kinase

Pulmonary Hypertension

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Danna Jennings, Sarah Huntwork-Rodriguez, Anastasia G Henry, Jennifer C Sasaki, René Meisner, Dolores Diaz, Hilda Solanoy, Xiang Wang, Elvira Negrou, Vitaliy V Bondar, Rajarshi Ghosh, Michael T Maloney, Nicholas E Propson, Yuda Zhu, Romeo D Maciuca, Laura Harris, Angela Kay, Peter A LeWitt, T Alex King, Drew Kern, Aaron Ellenbogen, Ira Goodman, Andrew Siderowf, Jason Aldred, Omid Omidvar, Shababa T Masoud, Sonnet S Davis, Annie Arguello, Anthony A Estrada, Javier de Vicente, Zachary K Sweeney, Giuseppe Astarita, Marie T Borin, Bradley K Wong, Harvey Wong, Hoang N Nguyen, Kimberly A Scearce-Levie, Carole Ho, Matthew D Troyer
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease. Science translational medicine 14 (648) (2022)
Marco A S Baptista, Kalpana Merchant, Edward G Barrett, Sakshi Bhargava, Dianne K Bryce, J Michael Ellis, Anthony A Estrada, Matthew J Fell, Brian K Fiske, Reina N Fuji, Paul Galatsis, Anastasia G Henry, Sue Hill, Warren Hirst, Christopher D Houle, Matthew E Kennedy, Xingrong Liu, Matthew L Maddess, Carrie Markgraf, Hong Mei, William A Meier, Elie Needle, Stephen Ploch, Christopher Royer, Karin Rudolph, Alok K Sharma, Antonia Stepan, Stefan Steyn, Craig Trost, Zhizhang Yin, Hongshi Yu, Xiang Wang, Todd B Sherer
LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits. Science translational medicine 12 (540) (2021)